Trimethoprim-sulfamethoxazole desensitization in AIDS

Papakonstantinou, G; Füeßl, H; Hehlmann, R

dc.contributor.author	Papakonstantinou, G	en
dc.contributor.author	Füeßl, H	en
dc.contributor.author	Hehlmann, R	en
dc.date.accessioned	2014-03-01T01:39:22Z
dc.date.available	2014-03-01T01:39:22Z
dc.date.issued	1988	en
dc.identifier.uri	https://dspace.lib.ntua.gr/xmlui/handle/123456789/22743
dc.subject	Mortality Rate	en
dc.subject	pneumocystis carinii pneumonia	en
dc.subject	pneumocystis carinii	en
dc.subject	Recommended Dose	en
dc.title	Trimethoprim-sulfamethoxazole desensitization in AIDS	en
heal.type	journalArticle	en
heal.identifier.primary	10.1007/BF01735793	en
heal.identifier.secondary	http://dx.doi.org/10.1007/BF01735793	en
heal.publicationDate	1988	en
heal.abstract	Summary Trimethoprim-sulfamethoxazole (TMS) desensitization was carried out in three patients with AIDS and Pneumocystis carinii pneumonia (PCP) in whom treatment with TMS had to be discontinued after 8 to 12 days due to an allergic reaction. Although the pneumonia was under control we decided for a desensitization to TMS because of the frequent reinfection and the high mortality rate particularly	en
heal.journalName	Journal of Molecular Medicine-jmm	en
dc.identifier.doi	10.1007/BF01735793	en